EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment

This review article reappraises the clinical use of EDTA chelation therapy, highlighting its effectiveness in removing toxic metals such as lead, cadmium, nickel, and aluminum. Based on recent clinical trials, EDTA therapy showed benefits such as a 50% reduction in urinary lead levels and improved systolic blood pressure in cardiovascular